The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Influenza Medication Market Research Report 2024
Synopsis
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
The global Influenza Medication market was valued at US$ 3064.6 million in 2023 and is anticipated to reach US$ 4762.8 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
This report aims to provide a comprehensive presentation of the global market for Influenza Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Medication.
Report Scope
The Influenza Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Segment by Type
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Segment by Application
Hospitals
Clinics
Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disorder are cold, cough, fever, and sore throat, which can be severe or mild. Seasonal outbreak of influenza primarily occurs in winter. Most people generally recover fully, but severe complications such as pneumonia can also develop. Initiation of antiviral treatment is recommended for hospitalized influenza patients. High growth of the global influenza medication market is due to unmet medical needs within the annual influenza epidemics along with strong R&D focus resulting in new and advanced treatments and drugs, and increasing demand due to government stockpiling.
The global Influenza Medication market was valued at US$ 3064.6 million in 2023 and is anticipated to reach US$ 4762.8 million by 2030, witnessing a CAGR of 6.5% during the forecast period 2024-2030.
In term of distribution channels, global influenza medications market is divided into hospitals, clinics, pharmacies and others. Incidence and prevalence of flu are gradually increasing across the globe. Of these, the pharmacies segment held dominance in 2017. Through the course of the forecast period, growth run witnessed by the segment is likely to remain steady due to the mushrooming pharmacy stores around the world. Besides this, the market is likely to witness lucrative prospects in the hospitals segment.
This report aims to provide a comprehensive presentation of the global market for Influenza Medication, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Influenza Medication.
Report Scope
The Influenza Medication market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Influenza Medication market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Influenza Medication manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International
Sun Pharmaceutical Industries
Mylan
Segment by Type
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Others
Segment by Application
Hospitals
Clinics
Pharmacies
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Influenza Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Influenza Medication in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Influenza Medication Market Overview
1.1 Product Overview and Scope of Influenza Medication
1.2 Influenza Medication Segment by Type
1.2.1 Global Influenza Medication Market Value Comparison by Type (2024-2030)
1.2.2 Zanamivir
1.2.3 Oseltamivir
1.2.4 Peramivir
1.2.5 Amantadine
1.2.6 Rimantadine
1.2.7 Inosine
1.2.8 Others
1.3 Influenza Medication Segment by Application
1.3.1 Global Influenza Medication Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Pharmacies
1.3.5 Others
1.4 Global Influenza Medication Market Size Estimates and Forecasts
1.4.1 Global Influenza Medication Revenue 2019-2030
1.4.2 Global Influenza Medication Sales 2019-2030
1.4.3 Global Influenza Medication Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Influenza Medication Market Competition by Manufacturers
2.1 Global Influenza Medication Sales Market Share by Manufacturers (2019-2024)
2.2 Global Influenza Medication Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Influenza Medication Average Price by Manufacturers (2019-2024)
2.4 Global Influenza Medication Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Influenza Medication, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Influenza Medication, Product Type & Application
2.7 Influenza Medication Market Competitive Situation and Trends
2.7.1 Influenza Medication Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Influenza Medication Players Market Share by Revenue
2.7.3 Global Influenza Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Influenza Medication Retrospective Market Scenario by Region
3.1 Global Influenza Medication Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Influenza Medication Global Influenza Medication Sales by Region: 2019-2030
3.2.1 Global Influenza Medication Sales by Region: 2019-2024
3.2.2 Global Influenza Medication Sales by Region: 2025-2030
3.3 Global Influenza Medication Global Influenza Medication Revenue by Region: 2019-2030
3.3.1 Global Influenza Medication Revenue by Region: 2019-2024
3.3.2 Global Influenza Medication Revenue by Region: 2025-2030
3.4 North America Influenza Medication Market Facts & Figures by Country
3.4.1 North America Influenza Medication Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Influenza Medication Sales by Country (2019-2030)
3.4.3 North America Influenza Medication Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Influenza Medication Market Facts & Figures by Country
3.5.1 Europe Influenza Medication Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Influenza Medication Sales by Country (2019-2030)
3.5.3 Europe Influenza Medication Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Influenza Medication Market Facts & Figures by Country
3.6.1 Asia Pacific Influenza Medication Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Influenza Medication Sales by Country (2019-2030)
3.6.3 Asia Pacific Influenza Medication Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Influenza Medication Market Facts & Figures by Country
3.7.1 Latin America Influenza Medication Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Influenza Medication Sales by Country (2019-2030)
3.7.3 Latin America Influenza Medication Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Influenza Medication Market Facts & Figures by Country
3.8.1 Middle East and Africa Influenza Medication Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Influenza Medication Sales by Country (2019-2030)
3.8.3 Middle East and Africa Influenza Medication Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Influenza Medication Sales by Type (2019-2030)
4.1.1 Global Influenza Medication Sales by Type (2019-2024)
4.1.2 Global Influenza Medication Sales by Type (2025-2030)
4.1.3 Global Influenza Medication Sales Market Share by Type (2019-2030)
4.2 Global Influenza Medication Revenue by Type (2019-2030)
4.2.1 Global Influenza Medication Revenue by Type (2019-2024)
4.2.2 Global Influenza Medication Revenue by Type (2025-2030)
4.2.3 Global Influenza Medication Revenue Market Share by Type (2019-2030)
4.3 Global Influenza Medication Price by Type (2019-2030)
5 Segment by Application
5.1 Global Influenza Medication Sales by Application (2019-2030)
5.1.1 Global Influenza Medication Sales by Application (2019-2024)
5.1.2 Global Influenza Medication Sales by Application (2025-2030)
5.1.3 Global Influenza Medication Sales Market Share by Application (2019-2030)
5.2 Global Influenza Medication Revenue by Application (2019-2030)
5.2.1 Global Influenza Medication Revenue by Application (2019-2024)
5.2.2 Global Influenza Medication Revenue by Application (2025-2030)
5.2.3 Global Influenza Medication Revenue Market Share by Application (2019-2030)
5.3 Global Influenza Medication Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Daiichi Sankyo Company
6.1.1 Daiichi Sankyo Company Corporation Information
6.1.2 Daiichi Sankyo Company Description and Business Overview
6.1.3 Daiichi Sankyo Company Influenza Medication Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Daiichi Sankyo Company Influenza Medication Product Portfolio
6.1.5 Daiichi Sankyo Company Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Corporation Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Influenza Medication Sales, Revenue and Gross Margin (2019-2024)
6.2.4 GlaxoSmithKline Influenza Medication Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Natco Pharma
6.3.1 Natco Pharma Corporation Information
6.3.2 Natco Pharma Description and Business Overview
6.3.3 Natco Pharma Influenza Medication Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Natco Pharma Influenza Medication Product Portfolio
6.3.5 Natco Pharma Recent Developments/Updates
6.4 F. Hoffmann-La Roche
6.4.1 F. Hoffmann-La Roche Corporation Information
6.4.2 F. Hoffmann-La Roche Description and Business Overview
6.4.3 F. Hoffmann-La Roche Influenza Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 F. Hoffmann-La Roche Influenza Medication Product Portfolio
6.4.5 F. Hoffmann-La Roche Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Influenza Medication Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Influenza Medication Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Sandoz International
6.6.1 Sandoz International Corporation Information
6.6.2 Sandoz International Description and Business Overview
6.6.3 Sandoz International Influenza Medication Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Sandoz International Influenza Medication Product Portfolio
6.6.5 Sandoz International Recent Developments/Updates
6.7 Sun Pharmaceutical Industries
6.6.1 Sun Pharmaceutical Industries Corporation Information
6.6.2 Sun Pharmaceutical Industries Description and Business Overview
6.6.3 Sun Pharmaceutical Industries Influenza Medication Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Sun Pharmaceutical Industries Influenza Medication Product Portfolio
6.7.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Influenza Medication Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Mylan Influenza Medication Product Portfolio
6.8.5 Mylan Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Influenza Medication Industry Chain Analysis
7.2 Influenza Medication Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Influenza Medication Production Mode & Process
7.4 Influenza Medication Sales and Marketing
7.4.1 Influenza Medication Sales Channels
7.4.2 Influenza Medication Distributors
7.5 Influenza Medication Customers
8 Influenza Medication Market Dynamics
8.1 Influenza Medication Industry Trends
8.2 Influenza Medication Market Drivers
8.3 Influenza Medication Market Challenges
8.4 Influenza Medication Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
